You are here

NKTR-181

Nektar takes a hit as the FDA swerves away from opioid reviews — leaving NKTR-181 in limbo

Endpoints

Fri, 07/26/19 - 11:57 am

Nektar Therapeutics

What Is Nektar Therapeutics' New Game Plan?

Motley Fool

Sun, 05/26/19 - 11:13 am

Nektar Therapeutics

non-opioid pain treatments

In a change of plans, Nektar spins out its opioid into a new biotech subsidiary as FDA PDUFA date looms

Endpoints

Thu, 05/23/19 - 09:52 am

Nektar Therapeutics

Inheris Biopharma

FDA pushes PDUFA for Nektar opioid analgesic

BioCentury

Thu, 02/28/19 - 09:16 pm

chronic low back pain

The opioid drug that addicts don't like could be approved next spring

Bizjournals.com

Thu, 08/2/18 - 10:07 am

Nektar Therapeutics

[video]What’s Next for Nektar Therapeutics?

Motley Fool

Sun, 11/19/17 - 09:47 am

Nektar's Pain Drug Disappoints

Yahoo/Zacks

Sat, 09/28/13 - 12:15 pm

pain management

Nektar Plummets After Pain Drug Misses Goals of Mid-Stage Study

Bloomberg

Fri, 09/27/13 - 11:41 am

Rough market day for Nektar, while Pharmacyclics and Regeneron soar

Marketwatch

Fri, 09/27/13 - 08:37 am

This Week in Biotech

Motley Fool

Sun, 06/23/13 - 11:11 am

pain management

prostage cancer

Nektar Therapeutics Gains on Trial of New Painkiller

Bloomberg

Wed, 06/19/13 - 04:01 pm

abuse-resistant painkillers

Nektar Therapeutics says FDA gives fast track incentives to chronic pain drug NKTR-181

Yahoo/AP

Fri, 06/8/12 - 11:52 am

Nektar starts trial on next-generation opioid

Bizjournals.com

Tue, 03/22/11 - 07:24 am

Nektar Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010

Yahoo/PR NewsWire

Sun, 11/14/10 - 12:41 pm

pain management

abuse-resistant painkillers